Southeastern Office - Wilmington. The Southeastern Region is home to an impressive clinical research industry cluster, strong assets for marine biotechnology commercialization, and significant ...

Califf completed his second term as FDA commissioner in January with the change in administrations. He’s only the second ...

In an all-digital world, how can a more hands-on, personalized marketing and sales approach be leveraged to strengthen human ...

Durham-based GeneCentric Therapeutics, a cancer diagnostics company, has closed on an $8 million round of venture capital to launch and commercialize a novel liquid biopsy platform for guiding ...

Upstream Biotechnology, a Durham-based developer of innovative crop varieties resilient to environmental stress, and Bene Seeds Inc., a California-based provider of high-quality tomato seed products, ...

North Carolina’s life sciences industry has crossed a milestone – exceeding 100,000 jobs for the first time – and continues to outpace national industry growth and most other top-tier life sciences ...

Among the many obstacles between idea and market in life sciences and biotechnology product development, the main challenge is securing capital. NCBiotech offers several business funding programs that ...

Only five days after FDA approval of Yutrepia, Liquidia announced its first commercial shipment of the therapy, making prescriptions available to patients at specialty pharmacies. “We have moved with ...

Hosted by Merck, this training will cover high-quality life sciences career opportunities in North Carolina and provide strategies for connecting community members to these opportunities. Want to make ...

The North Carolina Biotechnology Center is a life science economic development organization that helps bring ideas to market, grows North Carolina's cluster of life science companies to meet industry ...

The Flash Grant program aims to identify and energize creative ideas that exhibit early indications of commercial potential.Like a flash of inspiration, Flash Grants infuse a quick jolt of funding at ...

Genentech, considered one of the biotech industry’s founding companies, plans to build a $700 million, 700,000-square-foot manufacturing facility in Holly Springs. The company expects to employ 420 ...